A RAD51 inhibitor (IC50s = 5-30 μM); selectively inhibits homologous recombination without inhibiting single strand annealing; sensitizes cancer cells to chemotherapeutics that generate interstrand DNA crosslinks, including HEK293 cells co-treated with mitomycin C (LD50 = 16.62 μM)